LncRNA H19 overexpression induces bortezomib resistance in multiple myeloma by targeting MCL-1 via miR-29b-3p
出版年份 2019 全文链接
标题
LncRNA H19 overexpression induces bortezomib resistance in multiple myeloma by targeting MCL-1 via miR-29b-3p
作者
关键词
-
出版物
Cell Death & Disease
Volume 10, Issue 2, Pages -
出版商
Springer Nature
发表日期
2019-02-06
DOI
10.1038/s41419-018-1219-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Differential mRNA expression of the main apoptotic proteins in normal and malignant cells and its relation to in vitro resistance
- (2018) Andrea Vazanova et al. Cancer Cell International
- Serum level of long noncoding RNA H19 as a diagnostic biomarker of multiple myeloma
- (2018) Yafang Pan et al. CLINICA CHIMICA ACTA
- Small-molecule Mcl-1 inhibitors: Emerging anti-tumor agents
- (2018) Yichao Wan et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Patient-reported outcomes in relapsed/refractory multiple myeloma: a systematic review
- (2018) Francesco Sparano et al. SUPPORTIVE CARE IN CANCER
- Kanglaite reverses multidrug resistance of HCC by inducing apoptosis and cell cycle arrest via PI3K/AKT pathway
- (2018) Chendong Yang et al. OncoTargets and Therapy
- Common Adverse Effects of Novel Therapies for Multiple Myeloma (MM) and Their Management Strategies
- (2018) Kristen B. McCullough et al. Current Hematologic Malignancy Reports
- Deregulated expression of long non-coding RNA UCA1 in multiple myeloma
- (2017) Lenka Sedlarikova et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Long Noncoding RNA CRNDE Promotes Multiple Myeloma Cell Growth by Suppressing miR-451
- (2017) Yi-Bin Meng et al. ONCOLOGY RESEARCH
- LncRNA OIP5-AS1 loss-induced microRNA-410 accumulation regulates cell proliferation and apoptosis by targeting KLF10 via activating PTEN/PI3K/AKT pathway in multiple myeloma
- (2017) Nan Yang et al. Cell Death & Disease
- Voruciclib, a clinical stage oral CDK9 inhibitor, represses MCL-1 and sensitizes high-risk Diffuse Large B-cell Lymphoma to BCL2 inhibition
- (2017) Joyoti Dey et al. Scientific Reports
- Xbp1s-Negative Tumor B Cells and Pre-Plasmablasts Mediate Therapeutic Proteasome Inhibitor Resistance in Multiple Myeloma
- (2015) Chungyee Leung-Hagesteijn et al. CANCER CELL
- The Nuclear Factor (Erythroid-derived 2)-like 2 and Proteasome Maturation Protein Axis Mediate Bortezomib Resistance in Multiple Myeloma
- (2015) Bingzong Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Epigenetic silencing of a long non-coding RNA KIAA0495 in multiple myeloma
- (2015) Kwan Yeung Wong et al. Molecular Cancer
- H19 lncRNA mediates 17β-estradiol-induced cell proliferation in MCF-7 breast cancer cells
- (2015) HONG SUN et al. ONCOLOGY REPORTS
- Small molecule Mcl-1 inhibitors for the treatment of cancer
- (2015) Johannes Belmar et al. PHARMACOLOGY & THERAPEUTICS
- Upregulation of lncRNA MEG3 Promotes Osteogenic Differentiation of Mesenchymal Stem Cells From Multiple Myeloma Patients By Targeting BMP4 Transcription
- (2015) Wenzhuo Zhuang et al. STEM CELLS
- H19-derived miR-675 contributes to bladder cancer cell proliferation by regulating p53 activation
- (2015) Changkun Liu et al. TUMOR BIOLOGY
- Aflatoxin B1 Promotes Cell Growth and Invasion in Hepatocellular Carcinoma HepG2 Cells through H19 and E2F1
- (2014) Jun Lv et al. Asian Pacific Journal of Cancer Prevention
- MCL-1 dependency of cisplatin-resistant cancer cells
- (2014) Judith Michels et al. BIOCHEMICAL PHARMACOLOGY
- BAG3 upregulates Mcl-1 through downregulation of miR-29b to induce anticancer drug resistance in ovarian cancer
- (2014) Asuka Sugio et al. GYNECOLOGIC ONCOLOGY
- A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance
- (2013) Z. Tian et al. BLOOD
- Control of Autophagic Cell Death by Caspase-10 in Multiple Myeloma
- (2013) Laurence Lamy et al. CANCER CELL
- Sequence analysis of -subunit genes of the 20S proteasome in patients with relapsed multiple myeloma treated with bortezomib or dexamethasone
- (2012) D. I. Lichter et al. BLOOD
- Bortezomib resistance in a myeloma cell line is associated to PSMβ5 overexpression and polyploidy
- (2011) Patricia Balsas et al. LEUKEMIA RESEARCH
- Initial genome sequencing and analysis of multiple myeloma
- (2011) Michael A. Chapman et al. NATURE
- Bortezomib-resistant myeloma cell lines: a role for mutated PSMB5 in preventing the accumulation of unfolded proteins and fatal ER stress
- (2010) M Ri et al. LEUKEMIA
- Bortezomib-Resistant Nuclear Factor- B Activity in Multiple Myeloma Cells
- (2008) S. Markovina et al. MOLECULAR CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started